Global Pharmaceutical Launches
Marketing Budgets and Staffing (Phase 3 to Post-Launch)
| Publication Date | January 2005 |
|---|---|
| Publisher | Cutting Edge Information |
| Product Type | Report |
| Pages | 168 |
| ISBN Number | not applicable |
| Product Code | CUT00021 |
Summary
Global Pharmaceutical Launches: Marketing Budgets and Staffing (Phase III to Post-Launch) -- PH62
Align dollars and people for a winning drug launch. With spending and staffing data for the commercialization of 16 brands, this report analyzes launches across the industry -- including niche products with modest budgets, mid-level products balancing expenditures, and larger brands with blockbuster hopes.
The report breaks down brands' commercialization spending and headcounts into three time segments and four spending categories:
Time Segments
- Phase III
- Registration and Launch
- First 12-18 Months on market
- (For Pre-Clinical to Phase II data, visit PharmaCommercialization.com)
Spending Categories
- Brand activities
- Market research
- Thought leader development
- Advertising
The commercialization of new drugs continues to challenge companies across the pharmaceutical and biotechnology sectors. This report provides valuable assistance to individuals and teams who seek guidance in the allocation of pre- and post-launch marketing resources.
Content
- Each Chapter in Global Pharmaceutical Launches Contains Brand Profiles That Detail The following Metrics:
- Brand spending by time period (Phase III, Registration and Launch, and First 12-18 Months on market)
- Brand headcounts by time period (Phase III, Registration and Launch, and First 12-18 Months on market)
- Spending and staffing allocations for core brand activities in all three time periods
- Spending and staffing allocations for market research in all three time periods
- Spending and staffing allocations for thought leader development in all three time periods
- Spending and staffing allocations for advertising in in all three time periods
- Chapter-Wide Analysis Unites All Brand Data:
- Chapter One: total spending and staffing for brand activities, market research, thought leader development and advertising -- in all three time periods -- for all six brands with blockbuster expectations.
- Chapter Two: total spending and staffing for brand activities, market research, thought leader development and advertising -- in all three time periods -- for all five mid-level brands (projected peak annual sales of $500 million to $1 billion).
- Chapter Three: total spending and staffing for brand activities, market research, thought leader development and advertising -- in all three time periods -- for all five niche brands (projected peak annual sales of less than $500 million).
About this Product
Delivery Details
PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)
PRINT/CD-ROM:Despatched within 2 to 4 working days.
Related Products
Recently Viewed Products
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















